Publications

• Keep It Moving: Physical Activity in the Prevention of Obesity-Driven Pancreatic Cancer.Sogunro A, Muzumdar MD. Cancer Res. 2024 Sep 16. PMID: 39279380.
• Tracing the evolution of single-cell cancer 3D genomes: an atlas for cancer gene discovery.Liu M, Jin S, Agabiti SS, Jensen TB, Yang T, Radda JSD, Ruiz CF, Baldissera G, Rajaei M, Townsend JP, Muzumdar MD, Wang S. bioRxiv. 2024 Sep 9; 2024 Sep 9. PMID: 37546882.
• Perioperative Modified FOLFIRINOX for Resectable Pancreatic Cancer: A Nonrandomized Controlled Trial.Cecchini M, Salem RR, Robert M, Czerniak S, Blaha O, Zelterman D, Rajaei M, Townsend JP, Cai G, Chowdhury S, Yugawa D, Tseng R, Mejia Arbelaez C, Jiao J, Shroyer K, Thumar J, Kortmansky J, Zaheer W, Fischbach N, Persico J, Stein S, Khan SA, Cha C, Billingsley KG, Kunstman JW, Johung KL, Wiess C, Muzumdar MD, Spickard E, Aushev VN, Laliotis G, Jurdi A, Liu MC, Escobar-Hoyos L, Lacy J. JAMA Oncol. 2024 Aug 1. PMID: 38900452.
• Oligomeric organization of membrane proteins from native membranes at nanoscale spatial and single-molecule resolution.Walker G, Brown C, Ge X, Kumar S, Muzumdar MD, Gupta K, Bhattacharyya M. Nat Nanotechnol. 2024 Jan; 2023 Nov 27. PMID: 38012273.
• Decoding the obesity-cancer connection: lessons from preclinical models of pancreatic adenocarcinoma.Ruiz CF, Garcia C, Jacox JB, Lawres L, Muzumdar MD. Life Sci Alliance. 2023 Nov; 2023 Aug 30. PMID: 37648285.
• Erratum. Integrated Physiology of the Exocrine and Endocrine Compartments in Pancreatic Diseases: Workshop Proceedings. Diabetes 2023;72:433-448.Mastracci TL, Apte M, Amundadottir LT, Alvarsson A, Artandi S, Bellin MD, Bernal-Mizrachi E, Caicedo A, Campbell-Thompson M, Cruz-Monserrate Z, Ouaamari AE, Gaulton KJ, Geisz A, Goodarzi MO, Hara M, Hull-Meichle RL, Kleger A, Klein AP, Kopp JL, Kulkarni RN, Muzumdar MD, Naren AP, Oakes SA, Olesen SS, Phelps EA, Powers AC, Stabler CL, Tirkes T, Whitcomb DC, Yadav D, Yong J, Zaghloul NA, Pandol SJ, Sander M. Diabetes. 2023 Aug 1. PMID: 37116182.
• Integrated Physiology of the Exocrine and Endocrine Compartments in Pancreatic Diseases: Workshop Proceedings.Mastracci TL, Apte M, Amundadottir LT, Alvarsson A, Artandi S, Bellin MD, Bernal-Mizrachi E, Caicedo A, Campbell-Thompson M, Cruz-Monserrate Z, El Ouaamari A, Gaulton KJ, Geisz A, Goodarzi MO, Hara M, Hull-Meichle RL, Kleger A, Klein AP, Kopp JL, Kulkarni RN, Muzumdar MD, Naren AP, Oakes SA, Olesen SS, Phelps EA, Powers AC, Stabler CL, Tirkes T, Whitcomb DC, Yadav D, Yong J, Zaghloul NA, Pandol SJ, Sander M. Diabetes. 2023 Apr 1. PMID: 36940317.
• Determination of oligomeric organization of membrane proteins from native membranes at nanoscale-spatial and single-molecule resolution.Walker G, Brown C, Ge X, Kumar S, Muzumdar MD, Gupta K, Bhattacharyya M. bioRxiv. 2023 Feb 21; 2023 Feb 21. PMID: 36865290.
• Integrated Physiology of the Exocrine and Endocrine Compartments in Pancreatic Diseases: Workshop Proceedings.Mastracci TL, Apte M, Amundadottir LT, Alvarsson A, Artandi S, Bellin MD, Bernal-Mizrachi E, Caicedo A, Campbell-Thompson M, Cruz-Monserrate Z, El Ouaamari A, Gaulton KJ, Geisz A, Goodarzi MO, Hara M, Hull-Meichle RL, Kleger A, Klein AP, Kopp JL, Kulkarni RN, Muzumdar MD, Naren AP, Oakes SA, Olesen SS, Phelps EA, Powers AC, Stabler CL, Tirkes T, Whitcomb DC, Yadav D, Yong J, Zaghloul NA, Sander M, Pandol SJ. Pancreas. 2022 Oct 1. PMID: 37078927.
• 5-Fluorouracil efficacy requires anti-tumor immunity triggered by cancer-cell-intrinsic STING.Tian J, Zhang D, Kurbatov V, Wang Q, Wang Y, Fang D, Wu L, Bosenberg M, Muzumdar MD, Khan S, Lu Q, Yan Q, Lu J. EMBO J. 2021 Apr 1; 2021 Feb 22. PMID: 33615517.
• Endocrine-Exocrine Signaling Drives Obesity-Associated Pancreatic Ductal Adenocarcinoma.Chung KM, Singh J, Lawres L, Dorans KJ, Garcia C, Burkhardt DB, Robbins R, Bhutkar A, Cardone R, Zhao X, Babic A, Vayrynen SA, Dias Costa A, Nowak JA, Chang DT, Dunne RF, Hezel AF, Koong AC, Wilhelm JJ, Bellin MD, Nylander V, Gloyn AL, McCarthy MI, Kibbey RG, Krishnaswamy S, Wolpin BM, Jacks T, Fuchs CS, Muzumdar MD. Cell. 2020 May 14; 2020 Apr 17. PMID: 32304665.
• Identification of DHODH as a therapeutic target in small cell lung cancer.Li L, Ng SR, Colón CI, Drapkin BJ, Hsu PP, Li Z, Nabel CS, Lewis CA, Romero R, Mercer KL, Bhutkar A, Phat S, Myers DT, Muzumdar MD, Westcott PMK, Beytagh MC, Farago AF, Vander Heiden MG, Dyson NJ, Jacks T. Sci Transl Med. 2019 Nov 6. PMID: 31694929.
• iRGD-guided Tumor-penetrating Nanocomplexes for Therapeutic siRNA Delivery to Pancreatic Cancer.Lo JH, Hao L, Muzumdar MD, Raghavan S, Kwon EJ, Pulver EM, Hsu F, Aguirre AJ, Wolpin BM, Fuchs CS, Hahn WC, Jacks T, Bhatia SN. Mol Cancer Ther. 2018 Nov; 2018 Aug 10. PMID: 30097486.
• Differences in Nanoparticle Uptake in Transplanted and Autochthonous Models of Pancreatic Cancer.Tao Z, Muzumdar MD, Detappe A, Huang X, Xu ES, Yu Y, Mouhieddine TH, Song H, Jacks T, Ghoroghchian PP. Nano Lett. 2018 Apr 11; 2018 Mar 21. PMID: 29533667.
• Adaptive and Reversible Resistance to Kras Inhibition in Pancreatic Cancer Cells.Chen PY, Muzumdar MD, Dorans KJ, Robbins R, Bhutkar A, Del Rosario A, Mertins P, Qiao J, Schafer AC, Gertler F, Carr S, Jacks T. Cancer Res. 2018 Feb 15; 2017 Dec 26. PMID: 29279356.
• Survival of pancreatic cancer cells lacking KRAS function.Muzumdar MD, Chen PY, Dorans KJ, Chung KM, Bhutkar A, Hong E, Noll EM, Sprick MR, Trumpp A, Jacks T. Nat Commun. 2017 Oct 23; 2017 Oct 23. PMID: 29061961.
• Early tumor detection afforded by in vivo imaging of near-infrared II fluorescence.Tao Z, Dang X, Huang X, Muzumdar MD, Xu ES, Bardhan NM, Song H, Qi R, Yu Y, Li T, Wei W, Wyckoff J, Birrer MJ, Belcher AM, Ghoroghchian PP. Biomaterials. 2017 Jul; 2017 Apr 25. PMID: 28482280.
• Clonal dynamics following p53 loss of heterozygosity in Kras-driven cancers.Muzumdar MD, Dorans KJ, Chung KM, Robbins R, Tammela T, Gocheva V, Li CM, Jacks T. Nat Commun. 2016 Sep 2; 2016 Sep 2. PMID: 27585860.
• Targeting the HGF/c-MET pathway in hepatocellular carcinoma.Goyal L, Muzumdar MD, Zhu AX. Clin Cancer Res. 2013 May 1; 2013 Feb 6. PMID: 23388504.
• A global double-fluorescent Cre reporter mouse.Muzumdar MD, Tasic B, Miyamichi K, Li L, Luo L. Genesis. 2007 Sep. PMID: 17868096.
• Modeling sporadic loss of heterozygosity in mice by using mosaic analysis with double markers (MADM).Muzumdar MD, Luo L, Zong H. Proc Natl Acad Sci U S A. 2007 Mar 13; 2007 Mar 5. PMID: 17360552.
• Mosaic analysis with double markers in mice.Zong H, Espinosa JS, Su HH, Muzumdar MD, Luo L. Cell. 2005 May 6. PMID: 15882628.
• Sonic hedgehog is required for progenitor cell maintenance in telencephalic stem cell niches.Machold R, Hayashi S, Rutlin M, Muzumdar MD, Nery S, Corbin JG, Gritli-Linde A, Dellovade T, Porter JA, Rubin LL, Dudek H, McMahon AP, Fishell G. Neuron. 2003 Sep 11. PMID: 12971894.